# Foghorn Therapeutics Inc.: filings

FHTX · Nasdaq · CIK 1822462 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fhtx.md) · [Financials](/companies/fhtx/financials.md) · [Filings](/companies/fhtx/filings.md) · [Insiders](/companies/fhtx/insiders.md)

## Reports and events: 128 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 125, 8-K 89, 3 29, 10-Q 18, CORRESP 8, UPLOAD 7, 10-K 6, DEF 14A 6, S-8 6, 424B5 5, DEFA14A 5, SC 13G 5, SC 13G/A 5, SCHEDULE 13G/A 5, 3/A 4, ARS 4, EFFECT 4, 144 3, 10-K/A 2, 424B4 2, S-1/A 2, S-3 2, SEC STAFF LETTER 2, 10-Q/A 1, 8-A12B 1, CERT 1, DRS 1, POS AM 1, S-1 1, SC 13D 1, SC 13D/A 1, SCHEDULE 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-01 | 11:01 ET | [8-K](/filings/0001628280-26-064102.md) | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-064102 |
| 2026-08-06 | 11:03 ET | [10-Q](/filings/0001628280-26-053819.md) | Quarterly report, period 2026-06-30 | 0001628280-26-053819 |
| 2026-08-06 | 11:01 ET | [8-K](/filings/0001628280-26-053817.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-053817 |
| 2026-06-24 | 20:01 ET | [8-K](/filings/0001628280-26-045154.md) | 5.07 Shareholder vote results | 0001628280-26-045154 |
| 2026-05-07 | 11:02 ET | [10-Q](/filings/0001628280-26-031671.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031671 |
| 2026-05-07 | 11:01 ET | [8-K](/filings/0001628280-26-031669.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-031669 |
| 2026-04-30 | 11:00 ET | [DEF 14A](/filings/0001193125-26-193928.md) | Proxy statement, period 2026-06-24 | 0001193125-26-193928 |
| 2026-04-21 | 20:01 ET | [8-K](/filings/0001628280-26-026259.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-026259 |
| 2026-03-11 | 20:11 ET | [10-K](/filings/0001628280-26-016814.md) | Annual report, period 2025-12-31 | 0001628280-26-016814 |
| 2026-03-11 | 20:09 ET | [8-K](/filings/0001628280-26-016805.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-016805 |
| 2026-02-23 | 12:00 ET | [8-K](/filings/0001628280-26-010377.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-26-010377 |
| 2026-01-13 | 22:09 ET | [SCHEDULE 13D/A](/filings/0001193125-26-011881.md) | Ownership report, active investor, amended | 0001193125-26-011881 |
| 2026-01-12 | 13:50 ET | [8-K](/filings/0001193125-26-009885.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-009885 |
| 2025-12-04 | 12:00 ET | [8-K](/filings/0001628280-25-055215.md) | 5.02 Departure or appointment of officers or directors | 0001628280-25-055215 |
| 2025-11-07 | 21:33 ET | [8-K](/filings/0001628280-25-050683.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-050683 |
| 2025-11-05 | 12:04 ET | [10-Q](/filings/0001628280-25-049238.md) | Quarterly report, period 2025-09-30 | 0001628280-25-049238 |
| 2025-11-05 | 12:02 ET | [8-K](/filings/0001628280-25-049236.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-049236 |
| 2025-10-30 | 11:27 ET | [8-K](/filings/0001628280-25-047322.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-047322 |
| 2025-09-02 | 20:03 ET | [8-K](/filings/0001822462-25-000007.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001822462-25-000007 |
| 2025-08-05 | 11:31 ET | [10-Q](/filings/0001628280-25-037606.md) | Quarterly report, period 2025-06-30 | 0001628280-25-037606 |
| 2025-08-05 | 11:30 ET | [8-K](/filings/0001628280-25-037603.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-037603 |
| 2025-07-01 | 20:40 ET | [8-K](/filings/0001628280-25-033784.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001628280-25-033784 |
| 2025-06-17 | 20:01 ET | [8-K](/filings/0001628280-25-031819.md) | 5.07 Shareholder vote results | 0001628280-25-031819 |
| 2025-05-14 | 11:07 ET | [10-Q](/filings/0001628280-25-025312.md) | Quarterly report, period 2025-03-31 | 0001628280-25-025312 |
| 2025-05-14 | 11:05 ET | [8-K](/filings/0001628280-25-025302.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-025302 |
| 2025-05-05 | 12:00 ET | [DEF 14A](/filings/0001193125-25-112091.md) | Proxy statement, period 2025-06-17 | 0001193125-25-112091 |
| 2025-05-01 | 20:00 ET | [8-K](/filings/0001628280-25-021506.md) | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-021506 |
| 2025-04-28 | 20:06 ET | [8-K](/filings/0001628280-25-020257.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-020257 |
| 2025-03-24 | 20:00 ET | [8-K](/filings/0001628280-25-014475.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-014475 |
| 2025-03-20 | 20:31 ET | [8-K](/filings/0001628280-25-014136.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-25-014136 |
| 2025-03-06 | 21:16 ET | [10-K](/filings/0001628280-25-010933.md) | Annual report, period 2024-12-31 | 0001628280-25-010933 |
| 2025-03-06 | 21:08 ET | [8-K](/filings/0001628280-25-010916.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-010916 |
| 2025-02-03 | 12:00 ET | [8-K](/filings/0001628280-25-003385.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-003385 |
| 2025-01-24 | 21:00 ET | [8-K](/filings/0001628280-25-002466.md) | 3.01 Delisting notice | 0001628280-25-002466 |
| 2025-01-13 | 12:05 ET | [8-K](/filings/0001628280-25-001226.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-25-001226 |
| 2024-12-30 | 12:54 ET | [8-K](/filings/0001628280-24-052539.md) | 5.02 Departure or appointment of officers or directors | 0001628280-24-052539 |
| 2024-12-16 | 12:04 ET | [8-K](/filings/0001628280-24-051280.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-051280 |
| 2024-11-04 | 21:14 ET | [10-Q](/filings/0001628280-24-045006.md) | Quarterly report, period 2024-09-30 | 0001628280-24-045006 |
| 2024-11-04 | 21:12 ET | [8-K](/filings/0001628280-24-045000.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-045000 |
| 2024-10-10 | 11:15 ET | [8-K](/filings/0001628280-24-042630.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-042630 |
| 2024-08-08 | 11:04 ET | [10-Q](/filings/0001628280-24-035867.md) | Quarterly report, period 2024-06-30 | 0001628280-24-035867 |
| 2024-08-08 | 11:02 ET | [8-K](/filings/0001628280-24-035864.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-035864 |
| 2024-06-26 | 20:04 ET | [8-K](/filings/0001628280-24-030137.md) | 5.07 Shareholder vote results | 0001628280-24-030137 |
| 2024-06-03 | 20:02 ET | [8-K](/filings/0001628280-24-026294.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-026294 |
| 2024-05-24 | 21:00 ET | [SC 13D/A](/filings/0001193125-24-147157.md) | Ownership report, active investor, amended | 0001193125-24-147157 |
| 2024-05-23 | 11:03 ET | [8-K](/filings/0001628280-24-024811.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-024811 |
| 2024-05-22 | 20:05 ET | [8-K](/filings/0001193125-24-144934.md) | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-144934 |
| 2024-05-20 | 12:02 ET | [8-K](/filings/0001628280-24-024217.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-024217 |
| 2024-05-06 | 20:54 ET | [8-K](/filings/0001628280-24-020698.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001628280-24-020698 |
| 2024-05-06 | 11:03 ET | [10-Q](/filings/0001628280-24-020455.md) | Quarterly report, period 2024-03-31 | 0001628280-24-020455 |

Page 1 of 3. [Older](/companies/fhtx/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.